genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
The Italian Job: An Interview with Gene Therapist Federico Mingozzi
Coronavirus
A ‘Patch’-Work Solution to Vaccine Delivery
Bioinformatics
NVIDIA Powers Up in Drug Discovery
Coronavirus
Life Sciences Go Viral in Maryland
Coronavirus
One COVID-19 Shot, Two Approaches
News
Synthetic Biology
Minimal CRISPR-Cas3 System Makes Substantial Deletions
Biomarkers
Diagnostic for Detecting Alzheimer’s Earlier Developed
Cancer
How Melanoma Increases Immunotherapy Resistance
OMICs
Role of Gut Microbiome in Multiple Sclerosis Depends on Genetic Makeup
Genetics
Got to Go? Scientists Uncover Gene That Helps Sense a Full…
Insights
All
Trends for 2020
Bioprocessing
Digital Pharma Is a Major Cultural Change
Bioprocessing
Contract Manufacturer Sets Up for Fill-and-Finish Next-Generation Therapies
Gene Therapy
The Italian Job: An Interview with Gene Therapist Federico Mingozzi
Bioprocessing
Ori Biotech Raises $30 Million in Financing
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Synthetic Biology
Minimal CRISPR-Cas3 System Makes Substantial Deletions
Biomarkers
Diagnostic for Detecting Alzheimer’s Earlier Developed
Bioprocessing
Digital Pharma Is a Major Cultural Change
Bioprocessing
Counting Growth in Continuous Biomanufacturing Operations
Magazine
October 2020 Vol. 40 No. 10
Spatial: The Next Omics Frontier
October 2020 Vol. 40 No. 10
Gene Therapy Startups Extend Biotech’s Legacy
October 2020 Vol. 40 No. 10
Viral or Nonviral: Which Is Better for CRISPR-Based Therapies?
October 2020 Vol. 40 No. 10
The Chronicles of CRISPR
October 2020 Vol. 40 No. 10
Host Cell Protein Analysis Informs Risk Assessment
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Therapeutics
Generics
Generics
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Generics
Novartis Plans Phase III Trial of Hydroxychloroquine for COVID-19
Generics
Personalized, Combination Therapies Improve Cancer Patient Outcomes
Generics
Teva Axing 14,000 Positions, Shutting Facilities Worldwide
Generics
Gilead Licenses Rights for HIV-1 Treatment BIC
Generics
FDA Commits to Advancing Generics with New List, Faster Reviews
Generics
Perrigo Confirms Office Search by U.S. Justice Department
Generics
Teva to Shrink Workforce; Denies Up to 6,000 Jobs Will Go
Generics
Apotex Plans 150 New Jobs in $184M U.S. Expansion
Generics
Fresenius Kabi Earmarks $250M for Illinois Manufacturing Site Expansion
Generics
After Completing $39B Acquisition, Teva Does Another Generics Deal with Allergan
Generics
Sagent Buys Five ANDAs, Including Propofol, from Teva for $40M
Generics
Mylan to Acquire Meda for $9.9B
Generics
Mylan to Sell Seven Generics to Alvogen as FTC Clears Perrigo...
Generics
Biopharma Industry Blasts TPP Exclusivity Compromise
Generics
Merck & Co. Sells 2 NDAs to ANI Pharmaceuticals for $75M+
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
